We are live on ! Find out more
KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

2 hedge funds and large institutions have $270K invested in Karuna Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 325 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 328 → 2 (-326)

100% less funds holding in top 10

Funds holding in top 10: 26 → 0 (-26)

100% less capital invested

Capital invested by funds: $12B → $270K (-$12B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 325

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-326
Holders Change %
-99.39%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-26
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
325
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$46.5M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
-$1.34B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$1.02B
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$907M
4
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$858M
5
BlackRock
BlackRock
New York
-$638M
Name Holding Trade Value Shares
Change 		Change in
Stake
TS
51
Twin Securities
New York
– -$39.9M -126,206 Closed
Franklin Resources
52
Franklin Resources
California
– -$39.7M -125,488 Closed
ACA
53
Avoro Capital Advisors
New York
– -$39.6M -125,000 Closed
Bank of Nova Scotia
54
Bank of Nova Scotia
Ontario, Canada
– -$37.9M -119,810 Closed
Bank of America
55
Bank of America
North Carolina
– -$35.1M -110,962 Closed
UOC
56
UBS O'Connor
Illinois
– -$33.8M -106,800 Closed
ClearBridge Investments
57
ClearBridge Investments
New York
– -$33.5M -105,780 Closed
Allspring Global Investments
58
Allspring Global Investments
North Carolina
– -$32.3M -102,086 Closed
WCMNY
59
Westchester Capital Management (New York)
New York
– -$32M -101,166 Closed
DCM
60
Driehaus Capital Management
Illinois
– -$30.5M -96,424 Closed
New York State Common Retirement Fund
61
New York State Common Retirement Fund
New York
– -$29.5M -93,089 Closed
CC
62
Carlson Capital
Texas
– -$28.5M -90,000 Closed
LGM
63
Logos Global Management
California
– -$28.5M -90,000 Closed
FTM
64
First Turn Management
California
– -$27.7M -87,369 Closed
WIC
65
Water Island Capital
New York
– -$27.6M -87,325 Closed
Barclays
66
Barclays
United Kingdom
– -$26M -82,074 Closed
CPW
67
Catalyst Private Wealth
California
– -$24.6M -77,855 Closed
TCA
68
Taconic Capital Advisors
New York
– -$23.7M -75,000 Closed
SCM
69
Segantii Capital Management
Hong Kong
– -$23.6M -74,613 Closed
GCL
70
Glazer Capital LLC
New York
– -$22M -69,410 Closed
CGL
71
Clarius Group LLC
Washington
– -$21.9M -69,248 Closed
Corient Private Wealth
72
Corient Private Wealth
Florida
– -$21.7M -68,504 Closed
Point72 Asset Management
73
Point72 Asset Management
Connecticut
– -$20.5M -64,630 Closed
HSBC Holdings
74
HSBC Holdings
United Kingdom
– -$20.4M -64,557 Closed
Skandinaviska Enskilda Banken (SEB)
75
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$20.3M -64,273 Closed
1 2
3
4 5

KRTX Hedge Fund Activity: Q1 2024 in Review

2 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q1 2024, worth a combined $270K — down 100% from $12B a quarter earlier.

Sellers outnumbered buyers: 325 funds closed out of KRTX and 0 opened new positions — a net loss of 325 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Capital International Investors, exiting entirely with an estimated $1.34B sold.

  • 2 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q1 2024, down from 328 in Q4 2023.
  • Funds reported $270K of Karuna Therapeutics, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q1 2024 and 325 closed out, a net change of -325 holders.
  • The largest Karuna Therapeutics, Inc. Common Stock seller in Q1 2024 was Capital International Investors, an estimated $1.34B sold.

Based on aggregated 13F filings for Q1 2024.